SSGJ-613
SSGJ-613-HH-I-01
Phase 1 small_molecule active
Quick answer
SSGJ-613 for Systemic Juvenile Idiopathic Arthritis is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Systemic Juvenile Idiopathic Arthritis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active